BioLineRx Ltd.
BLRX · NASDAQ
11/24/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $13,823 | $18,049 | $236,375 | $683,570 |
| - Cash | $0 | $7,189 | $9,036 | $10,436 |
| + Debt | $0 | $12,603 | $13,742 | $15,040 |
| Enterprise Value | $13,823 | $23,463 | $241,081 | $688,174 |
| Revenue | $4,943 | $304 | $255 | $11,749 |
| % Growth | 1,526% | 19.2% | -97.8% | – |
| Gross Profit | $4,121 | $232 | $221 | $5,660 |
| % Margin | 83.4% | 76.3% | 86.7% | 48.2% |
| EBITDA | $0 | -$3,488 | $5,712 | $3,100 |
| % Margin | 0% | -1,147.4% | 2,240% | 26.4% |
| Net Income | -$5,822 | -$3,940 | $5,127 | -$3,187 |
| % Margin | -117.8% | -1,296.1% | 2,010.6% | -27.1% |
| EPS Diluted | -1.47 | -1 | 0.065 | -0.041 |
| % Growth | -47% | -1,650.4% | 259.3% | – |
| Operating Cash Flow | – | -$177 | -$2,591 | -$8,610 |
| Capital Expenditures | – | $0 | $0 | $6 |
| Free Cash Flow | – | -$177 | -$2,591 | -$8,605 |